This paper describes a case report of an HIV-infected patient with muc
ocutaneous Kaposi's sarcoma (KS) with oral involvement, which presente
d complete clinical resolution of lesions on antiretroviral treatment
with ritonavir, an HIV-1 protease inhibitor. Although it has still not
been demonstrated that ritonavir has a specific antiviral action agai
nst HHV-8, a gamma herpesvirus probably involved in KS aetiopathogenes
is, it has been proven that it reduces the HIV load significantly. Thi
s affects certain growth factors of KS, such as Tat protein and cytoki
nes, and favours recovery of immune function, which correlates with pr
otection against AIDS-defining conditions. (C) 1998 Published by Elsev
ier Science Ltd. All rights reserved.